Who Should Consider It

Who should consider OncoVeryx?

OncoVeryx is for adults who want to be proactive about cancer screening. Your suitability is confirmed with a healthcare professional.

Suitability is always determined through healthcare guidance. This page is educational, not a recommendation to test.

Adults interested in proactive screening

Adults who want to take a proactive approach to their health and cancer screening.

People with a family history of cancer

Individuals who want to discuss their family history and screening options with a healthcare professional.

Executive health screening

Professionals who include comprehensive screening as part of a regular executive health review.

Employer wellness programmes

Teams participating in consent-based, doctor-led corporate wellness screening programmes.

Individuals seeking additional screening support

People who want an additional screening signal alongside the routine screening recommended by their provider.
Why timing matters

Finding cancer early changes everything.

When cancer is found early, before it spreads, treatment is far more effective. The numbers below show the difference that timing makes.

Rising outcome curve climbing along a calm timeline

Earlier-stage cancers are more treatable, with a wider range of options available and higher success rates.

Many cancers are only investigated once symptoms appear. Screening prompts earlier conversations.

Detected at an early, localised stageDetected after it has spread

Breast cancer

0%
0%

Cervical cancer

0%
0%

Colorectal cancer

0%
0%

Melanoma (skin)

0%
0%

Lung cancer

0%
0%

Figures show 5-year relative survival by stage at diagnosis (source: SEER, US National Cancer Institute). These are general population statistics, not results from OncoVeryx.

About these figures: the survival percentages above are general population statistics for 5-year relative survival by stage at diagnosis (source: SEER, US National Cancer Institute). They illustrate how outcomes for many cancers differ when disease is found early versus after it has spread. They are not results from OncoVeryx and do not represent an outcome guaranteed or demonstrated by this test. Survival depends on cancer type, individual factors and treatment. OncoVeryx is a screening tool that does not diagnose cancer. A positive result requires clinical evaluation, and a negative result does not rule out cancer.

Suitability is a conversation, not a checklist.

The best way to understand whether OncoVeryx is right for you is to speak with a healthcare professional who can consider your history, current screening and personal circumstances.

Screening is not diagnosis

OncoVeryx does not confirm cancer and does not rule out all cancers. False positive and false negative results can occur. Continue with routine cancer screening recommended by your healthcare provider.

Have a question about suitability?

Our team will guide you through the pathway and connect you with a healthcare professional.